{"id":"https://openalex.org/W4252748964","doi":"https://doi.org/10.3410/f.732759187.793573528","title":"Faculty Opinions recommendation of Gamma-delta (\u03b3\u03b4) T cells: friend or foe in cancer development?","display_name":"Faculty Opinions recommendation of Gamma-delta (\u03b3\u03b4) T cells: friend or foe in cancer development?","publication_year":2020,"publication_date":"2020-04-15","ids":{"openalex":"https://openalex.org/W4252748964","doi":"https://doi.org/10.3410/f.732759187.793573528"},"language":"en","primary_location":{"id":"doi:10.3410/f.732759187.793573528","doi":"https://doi.org/10.3410/f.732759187.793573528","is_oa":false,"landing_page_url":"https://doi.org/10.3410/f.732759187.793573528","pdf_url":null,"source":{"id":"https://openalex.org/S4363604054","display_name":"Faculty Opinions \u2013 Post-Publication Peer Review of the Biomedical Literature","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Faculty Opinions \u2013 Post-Publication Peer Review of the Biomedical Literature","raw_type":"dataset"},"volume":null,"type":"peer-review","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002152110","display_name":"David L. Wiest","orcid":"https://orcid.org/0000-0002-0792-3188","observed_orcids":["https://orcid.org/0000-0002-0792-3188"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Wiest","raw_affiliation_strings":["Blood Cell Development and Function Program, Fox Chase Cancer Center, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood Cell Development and Function Program, Fox Chase Cancer Center, USA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068253209","display_name":"Alejandra Virginia Contreras","orcid":"https://orcid.org/0000-0003-3653-5958","observed_orcids":["https://orcid.org/0000-0003-3653-5958"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandra Contreras","raw_affiliation_strings":["Fox Chase Cancer Center, USA"],"raw_orcid":"https://orcid.org/0000-0003-3653-5958","affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, USA","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1289437631"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.7656000256538391,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.7656000256538391,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.13650000095367432,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.04580000042915344,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gamma-delta-t-cells","display_name":"\u03b3\u03b4 T cells","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/t-cell-polarization","display_name":"T cell polarization","score":0.7979999780654907},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.7940000295639038},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7799999713897705},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8040000200271606},{"id":"https://openalex.org/keywords/innate-adaptive-immune-bridge","display_name":"innate-adaptive immune bridge","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6421971321105957},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6015005111694336},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5719811916351318},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5409402251243591},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5234457850456238},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5060035586357117},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4733930826187134},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4622066020965576},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.4614608883857727},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43848344683647156},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34950608015060425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15443649888038635}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3410/f.732759187.793573528","doi":"https://doi.org/10.3410/f.732759187.793573528","is_oa":false,"landing_page_url":"https://doi.org/10.3410/f.732759187.793573528","pdf_url":null,"source":{"id":"https://openalex.org/S4363604054","display_name":"Faculty Opinions \u2013 Post-Publication Peer Review of the Biomedical Literature","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Faculty Opinions \u2013 Post-Publication Peer Review of the Biomedical Literature","raw_type":"dataset"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1494453913","https://openalex.org/W1833274343","https://openalex.org/W1969669223","https://openalex.org/W1972013175","https://openalex.org/W2026130798","https://openalex.org/W2063011414","https://openalex.org/W2075094265","https://openalex.org/W2077492033","https://openalex.org/W2098308961","https://openalex.org/W2104666297","https://openalex.org/W2126259300","https://openalex.org/W2134108915","https://openalex.org/W2153300538","https://openalex.org/W2185409974","https://openalex.org/W2197796223","https://openalex.org/W2214494869","https://openalex.org/W2218610501","https://openalex.org/W2313244238","https://openalex.org/W2421681513","https://openalex.org/W2525994542","https://openalex.org/W2566162725","https://openalex.org/W2569464488","https://openalex.org/W2598349249","https://openalex.org/W2770977049"],"related_works":["https://openalex.org/W2784311950","https://openalex.org/W2559655923","https://openalex.org/W3131317870","https://openalex.org/W3084509318","https://openalex.org/W2950477675","https://openalex.org/W4318220495","https://openalex.org/W2042552886","https://openalex.org/W4313888795","https://openalex.org/W4312540259","https://openalex.org/W7204805944"],"abstract_inverted_index":{"Background:":[0],"\u03b3\u03b4":[1,36,60,82,88,112,130,158,180,208,220,244,257,280],"T":[2,9,12,37,61,83,89,113,131,159,181,209,221,245,258,281],"cells":[3,10,38,62,114,132,210,222,228,231,282],"are":[4,187],"a":[5,27,68,128,134,277],"distinct":[6],"subgroup":[7,260],"of":[8,47,59,70,81,87,99,148,157,172,178,203,252,279],"containing":[11],"cell":[13,90,160,259],"receptors":[14],"(TCRs)":[15],"\u03b3":[16],"and":[17,24,32,52,124,137,146,169,175,189,191,275],"TCR":[18],"\u03b4":[19],"chains":[20],"with":[21,94,216,243,285],"diverse":[22],"structural":[23,174],"functional":[25,176],"heterogeneity.As":[26],"bridge":[28],"between":[29],"the":[30,57,73,78,85,105,153,167,217,235,239,250,254,268,272],"innate":[31],"adaptive":[33],"immune":[34,42,286],"systems,":[35],"participate":[39],"in":[40,63,199,212,271],"various":[41],"responses":[43],"during":[44],"cancer":[45,64,118,126,200,273],"progression.Because":[46],"their":[48],"direct/indirect":[49],"antitumor":[50,122,168,205,227],"cytotoxicity":[51],"strong":[53],"cytokine":[54,269],"production":[55],"ability,":[56],"use":[58],"immunotherapy":[65,91,284],"has":[66,109],"received":[67],"lot":[69],"attention":[71],"over":[72,104],"past":[74,106],"decade.Main":[75],"text:":[76],"Despite":[77],"promising":[79],"potential":[80],"cells,":[84,182],"efficacy":[86,241],"is":[92],"limited,":[93],"an":[95],"average":[96],"response":[97],"ratio":[98],"only":[100],"21%.In":[101],"addition,":[102],"research":[103],"2":[107],"years":[108],"shown":[110],"that":[111,219],"could":[115],"also":[116],"promote":[117],"progression":[119],"by":[120],"inhibiting":[121],"responses,":[123],"enhancing":[125],"angiogenesis.As":[127],"result,":[129],"have":[133],"dual":[135],"effect":[136],"can":[138,223],"therefore":[139],"be":[140,224,234],"considered":[141],"as":[142],"being":[143],"both":[144,204],"\"friends\"":[145],"\"foes\"":[147],"cancer.In":[149],"order":[150],"to":[151,196,229,233],"solve":[152],"sub-optimal":[154],"efficiency":[155],"problem":[156],"immunotherapy,":[161,214],"we":[162],"review":[163],"recent":[164],"observations":[165],"regarding":[166],"protumor":[170,207,230,256],"activities":[171],"major":[173],"subsets":[177,186],"human":[179],"describing":[183],"how":[184,192],"these":[185,193],"activated":[188],"polarized,":[190],"events":[194],"relate":[195],"subsequent":[197],"effects":[198],"immunity.A":[201],"mixture":[202],"or":[206],"used":[211],"adoptive":[213,265,283],"coupled":[215],"fact":[218],"polarized":[225],"from":[226],"appear":[232],"likely":[236],"reasons":[237],"for":[238],"mild":[240],"seen":[242],"cells.":[246],"Conclusion:The":[247],"future":[248],"holds":[249],"promise":[251],"depleting":[253],"specific":[255],"before":[261],"therapy,":[262,266],"choosing":[263],"multi-immunocyte":[264],"modifying":[267],"balance":[270],"microenvironment,":[274],"using":[276],"combination":[278],"checkpoint":[287],"inhibitors.":[288]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}